Fluvastatin alleviates doxorubicin-induced cardiac and renal toxicity in rats via regulation of oxidative stress, inflammation, and apoptosis associated genes expressions

References

• Abdel-Raheem, I.T., Taye, A., and Abouzied, M.M., 2013. Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats. Basic & Clinical Pharmacology & Toxicology, 113 (3), 158–166.
   PubMed Web of Science ®Google Scholar
• Ayla, S., et al., 2011. Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. International Journal of Cell Biology, 2011, 390238.
   PubMedGoogle Scholar
• Bagchi, A.K., et al., 2021. Endoplasmic reticulum stress promotes iNOS/NO and influences inflammation in the development of doxorubicin-induced cardiomyopathy. Antioxidants, 10 (12), 1897.
   Web of Science ®Google Scholar
• Bahadır, A., et al., 2014. The role of nitric oxide in doxorubicin-induced cardiotoxicity: experimental study. Turkish Journal of Haematology, 31 (1), 68–74.
   PubMed Web of Science ®Google Scholar
• Billingham, M.E., et al., 1978. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treatment Reports, 62 (6), 865–872.
   PubMedGoogle Scholar
• Chong, L.W., et al., 2015. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. BMC Gastroenterology, 15 (1), 1–13.
   PubMed Web of Science ®Google Scholar
• Cui, X., et al., 2017. Protective effects of fluvastatin on reproductive function in obese male rats induced by high-fat diet through enhanced signaling of mTOR. Cellular Physiology and Biochemistry : international Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 41 (2), 598–608.
   PubMed Web of Science ®Google Scholar
• El-Moselhy, M.A., and El-Sheikh, A.A.K., 2014. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 68 (1), 101–110.
   PubMed Web of Science ®Google Scholar
• Garg, K., et al., 2012. Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible. International Journal of Gynecological Pathology, 31 (1), 48–56.
   PubMed Web of Science ®Google Scholar
• Gazia, M.A., and El-Magd, M.A., 2018. Ameliorative effect of cardamom aqueous extract on doxorubicin-induced cardiotoxicity in rats. Cells, Tissues, Organs, 206 (1-2), 62–72.
   PubMed Web of Science ®Google Scholar
• Gurel, C., et al., 2019. Fluvastatin attenuates doxorubicin-induced testicular toxicity in rats by reducing oxidative stress and regulating the blood-testis barrier via mTOR signaling pathway. Human & Experimental Toxicology, 38 (12), 1329–1343.
   PubMed Web of Science ®Google Scholar
• Habibi, F., et al., 2016. Alteration in inflammation-related miR-146a expression in NF-KB signaling pathway in diabetic rat hippocampus. Advanced Pharmaceutical Bulletin, 6 (1), 99–103.
   PubMedGoogle Scholar
• Hartner, A., et al., 2009. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt t hypertension. Journal of Hypertension, 27 (2), 376–385.
   PubMed Web of Science ®Google Scholar
• He, X., Sun, J., and Huang, X., 2018. Expression of caspase-3, Bax and Bcl-2 in hippocampus of rats with diabetes and subarachnoid hemorrhage. Experimental and Therapeutic Medicine, 15 (1), 873–877.
   PubMed Web of Science ®Google Scholar
• Hu, H., et al., 2022. Dexrazoxane alleviated doxorubicin-induced nephropathy in rats. Pharmacology, 1–10. doi:10.1159/000521220
   Web of Science ®Google Scholar
• Huang, K.M., et al., 2021. Targeting OCT3 attenuates doxorubicin-induced cardiac injury. Proceedings of the National Academy of Sciences of the United States of America, 118, 1–9.
   Web of Science ®Google Scholar
• Ibrahim, K.M., et al., 2020. Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles. Naunyn-Schmiedeberg's Archives of Pharmacology, 393 (4), 739–748.
   PubMed Web of Science ®Google Scholar
• Imaeda, A., et al., 2002. Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 40 (10), 1415–1422.
   PubMed Web of Science ®Google Scholar
• Khames, A., et al., 2019. Nicorandil combats doxorubicin-induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway . Chemico-Biological Interactions, 311, 108777–108778.
   PubMed Web of Science ®Google Scholar
• Kihara, M., et al., 2021. Salmon acyl-ghrelin increases food intake and reduces doxorubicin-induced myocardial apoptosis in rats, likely by anti-oxidative activity. Peptides, 137, 170471.
   PubMed Web of Science ®Google Scholar
• Kosić, M., et al., 2022. Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival. Biomed Pharmacother, 145, 112411.
   PubMed Web of Science ®Google Scholar
• Liu, M., et al., 2006. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. Journal of the American Society of Nephrology, 17 (3), 765–774.
   PubMed Web of Science ®Google Scholar
• Miwa, S., et al., 2005. Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocrine Journal, 52 (2), 259–264.
   PubMed Web of Science ®Google Scholar
• Mohamed, E.A., and Kassem, H.H., 2018. Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats. Archives of Medical Science, 14 (6), 1450–1458.
   PubMed Web of Science ®Google Scholar
• Neilan, T.G., et al., 2007. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin. Circulation, 116 (5), 506–514.
   PubMed Web of Science ®Google Scholar
• Nergiz, I., et al., 2012. Effects of rotenone on inducible nitric oxide synthase and cyclooxygenase-2 mRNA levels detected by real-time PCR in a rat bladder ischemia/reperfusion model. Experimental and Therapeutic Medicine, 4 (2), 344–348.
   PubMed Web of Science ®Google Scholar
• Octavia, Y., et al., 2012. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52, 1225.
   Web of Science ®Google Scholar
• Okubo, K., et al., 2020. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells. Cancer Science, 111 (1), 112–126.
   PubMed Web of Science ®Google Scholar
• Oltulu, F., et al., 2019. Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions. Turkish Journal of Medical Sciences, 49 (5), 1582–1589.
   PubMed Web of Science ®Google Scholar
• Rao, X., et al., 2013. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, Bioinformatics and Biomathematics, 3 (3), 71–85.
   PubMedGoogle Scholar
• Rehman, M.U., et al., 2014. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats. Experimental Biology and Medicine, 239, 465–476.
   PubMed Web of Science ®Google Scholar
• Renu, K., et al., 2018. Molecular mechanism of doxorubicin-induced cardiomyopathy: An update. European Journal of Pharmacology, 818, 241–253.
   PubMed Web of Science ®Google Scholar
• Riad, A., et al., 2009. Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice. Cancer Research, 69 (2), 695–699.
   PubMed Web of Science ®Google Scholar
• Sadek, K.M., et al., 2021. Proanthocyanidin alleviates doxorubicin-induced cardiac injury by inhibiting NF-kB pathway and modulating oxidative stress, cell cycle, and fibrogenesis. Journal of Biochemical and Molecular Toxicology, 35 (4), e22716.
   PubMed Web of Science ®Google Scholar
• Sanajou, D., et al., 2019. β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 392 (5), 633–640.
   PubMed Web of Science ®Google Scholar
• Shaker, M.E., et al., 2020. The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies. Toxicology and Applied Pharmacology, 398, 115018.
   PubMed Web of Science ®Google Scholar
• Su, Z., et al., 2015. Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro. Scientific Reports, 5, 18314–18314.
   PubMed Web of Science ®Google Scholar
• Ramanjaneyulu, S.V.V.S., et al., 2013. Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice. Journal of Physiology and Biochemistry, 69 (3), 513–525.
   PubMed Web of Science ®Google Scholar
• Tsirpanlis, G., et al., 2004. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients. Blood Purification, 22 (6), 518–524.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2021. Protection against doxorubicin-induced cardiotoxicity through modulating iNOS/ARG 2 balance by electroacupuncture at PC6. Oxidative Medicine and Cellular Longevity, 2021, 6628957
   PubMed Web of Science ®Google Scholar
• Xiang, C., Yan, Y., and Zhang, D., 2021. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro. Journal of Pharmacological Sciences, 145 (1), 6–15.
   PubMed Web of Science ®Google Scholar
• Xu, A., et al., 2020. NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 130, 110525.
   PubMed Web of Science ®Google Scholar
• Xu, L.J., et al., 2006. Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin. Acta Pharmacol Sin, 27 (10), 1333–1339.
   PubMed Web of Science ®Google Scholar
• Xu, S.Z., et al., 2008. Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2. Journal of Thrombosis and Haemostasis : JTH, 6 (4), 692–700.
   PubMed Web of Science ®Google Scholar
• Yang, Z., et al., 2017. Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy. EBioMedicine, 19, 49–59.
   PubMed Web of Science ®Google Scholar
• Yildiz, A., et al., 2015. Fluvastatin decreases oxidative stress in kidney transplant patients. Transplantation Proceedings, 47 (10), 2870–2874.
   PubMed Web of Science ®Google Scholar
• Yuan, G.J., et al., 2006. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World Journal of Gastroenterology, 12 (15), 2375–2381.
   PubMed Web of Science ®Google Scholar
• Zanetti, S.R., Maldonado, E.N., and Aveldaño, M.I., 2007. Doxorubicin affects testicular lipids with long-chain (C18-C22) and very long-chain (C24-C32) polyunsaturated fatty acids . Cancer Research, 67 (14), 6973–6980.
   PubMed Web of Science ®Google Scholar
• Zhong, L., et al., 2021. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy, 2021 616, 1–48.
   Google Scholar